Stock Screener App

무료 - Play StoreApp Store

설치하다 설치하다

OGN

$13.820.14%-0.02

프리마켓: 13.81-0.01 -0.07%

Organon Co (OGN)

Date: O: H: L: C: Vol:

Organon Co 주식(OGN)의 최신 뉴스

Organon Highlights Non-GAAP Metrics Amid Pending Merger - TipRanks

Form 8K Organon & Co For: 30 October By Investing.com - Investing.com Canada

Organon declares $0.02 quarterly dividend payable in December By Investing.com - Investing.com India

Organon: Q3 Earnings Snapshot - Yahoo Finance

Organon: Q3 Earnings Snapshot - WWLTV.com

Organon Announces Quarterly Dividend - Business Wire

Organon 3Q 2026: Revenue $1.57B, Net income $164M, EPS $0.6— 10-Q Summary - TradingView

Form 10-Q Organon & Co. For: Sep 30 - StreetInsider

Q3 revenue fell to $1.57B at Organon (OGN), but profit moved the other way. - Stock Titan

Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong - Reuters

Organon & Co. (OGN) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada

Organon & Co stock hits 52-week high at 13.83 USD - Investing.com

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Organon & Co. (OGN) options chain - Yahoo Finance UK

Organon set to report earnings ahead of Sun Pharma merger - Investing.com

OGN Q3'26 Earnings: EPS estimate is 0.88 USD - TradingView

Entera Bio names Organon CMO to its board of directors - StreetInsider

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Weekly Recap: Sun Pharma deal for Organon & Co. and No Q3 '26 milestones - TradingView

Organon & Co. Estimates – NYSE:OGN - TradingView

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Sun Pharma to raise Rs 10,000 crore to part-finance Organon deal - The Economic Times

Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026 - TradingView

Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing - Business Wire

Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada

Organon reports six‑year MIUDELLA data as FDA reviews longer use - Mugglehead Investment Magazine

Organon & Co - FDA Accepts Snda for Miudella - Moomoo

Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting - Business Wire

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Zacks Investment Research

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance

USU6836GAB42 Bond Yield and Price — BONDSCOM:USU6836GAB42 - TradingView

Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada

Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Organon & Co stock hits 52-week high at 13.79 USD - Investing.com

Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - Zacks Investment Research

Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - Yahoo Finance

Organon presents VTAMA analysis: Organon stock gains 1.16 percent - AD HOC NEWS

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference - Business Wire

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Tangible book value per share of Organon & Co. – HAN:7XP - TradingView

Organon & Co. Revenue Breakdown – HAN:7XP - TradingView

Sun Pharma plans $1 billion local debt sale for loan takeout, sources say - ETPharma.com

Sun Pharma plans $1 billion rupee debt sale to refinance Organon acquisition loan - Firstpost

Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada

Organon & Co. (OGN) Stock forecasts - Yahoo Finance Singapore

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Precision Trading with Organon & Co. (OGN) Risk Zones - Stock Traders Daily

OGN와(과) 유사한 종목

AMRN$12.130.17%

MIRA$0.53722.06%